Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
more »
- Duke Univ., Durham, NC (United States). Medical Center
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Each year, >180,000 infants become infected via mother-to-child transmission (MTCT) of HIV despite the availability of effective maternal antiretroviral treatments, underlining the need for a maternal HIV vaccine. We characterized 224 maternal HIV envelope (Env)-specific IgG monoclonal antibodies (MAbs) from seven nontransmitting and transmitting HIV-infected U.S. and Malawian mothers and examined their neutralization activities against nontransmitted autologous circulating viruses and infant-transmitted founder (infant-T/F) viruses. Only a small subset of maternal viruses, 3 of 72 (4%), were weakly neutralized by maternal linear V3 epitope-specific IgG MAbs, whereas 6 out of 6 (100%) infant-T/F viruses were neutralization resistant to these V3-specific IgG MAbs. We also show that maternal-plasma broadly neutralizing antibody (bNAb) responses targeting the V3 glycan supersite in a transmitting woman may have selected for an N332 V3 glycan neutralization-resistant infant-T/F virus. These data have important implications for bNAb-eliciting vaccines and passively administered bNAbs in the setting of MTCT.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA); National Institutes of Health (NIH)
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 1767003
- Report Number(s):
- LA-UR--21-20585
- Journal Information:
- mBio (Online), Journal Name: mBio (Online) Journal Issue: 2 Vol. 11; ISSN 2150-7511
- Publisher:
- American Society for Microbiology (ASM)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers
Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
Journal Article
·
Fri Apr 02 00:00:00 EDT 2021
· PLoS Pathogens
·
OSTI ID:1804370
Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
Journal Article
·
Thu Apr 19 00:00:00 EDT 2018
· PLoS Pathogens
·
OSTI ID:1627917
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
Journal Article
·
Wed Nov 16 23:00:00 EST 2022
· PLoS Pathogens
·
OSTI ID:2423892